Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Linda Catherine Lacerte"'
Autor:
Nathan Fowler, Sattva S. Neelapu, Seema Rawal, Michael J. Wallace, David J. Delgado, R. Eric Davis, Min Zhang, Rakesh Sharma, Tariq Muzzafar, Linda Catherine Lacerte, Veerabhadran Baladandayuthapani, Felipe Samaniego, Nusrat Harun, Carla Heise, Zhiqiang Wang
Publikováno v:
Blood. 120:2766-2766
Abstract 2766 Background: Lenalidomide plus rituximab therapy is a highly effective and well-tolerated therapy in patients (pts) with follicular lymphoma (FL). In a Phase II trial, this combination induced a complete remission rate of 87% in pts with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a0ffc2e0c7ba17f890f106fde32e3f2
https://doi.org/10.1182/blood.v120.21.2766.2766
https://doi.org/10.1182/blood.v120.21.2766.2766
Autor:
Yasuhiro Oki, Robert Z. Orlowski, Francesco Turturro, Fredrick B. Hagemeister, Linda Catherine Lacerte, Felipe Samaniego, Peter McLaughlin, Jorge E. Romaguera, Sattva S. Neelapu, Luis Fayad, Nathan Fowler, Larry W. Kwak, Michael Wang, Michelle A. Fanale
Publikováno v:
Blood. 120:901-901
Abstract 901 Background: The optimal management of patients (pts) with untreated, advanced stage indolent non-Hodgkins lymphoma (NHL) is evolving. Although several traditional chemo-immunotherapy regimens achieve high overall response (OR) rates, tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0b93b5dbf84a0528e96a3d1f0875d2c
https://doi.org/10.1182/blood.v120.21.901.901
https://doi.org/10.1182/blood.v120.21.901.901